Archive: 19/12/2016
Researchers provide molecular portraits of a new cancer drug target
Unprecedented images of cancer genome-mutating enzymes acting on DNA provide vital clues into how the enzymes work to promote tumor evolution and drive poor disease outcomes. These images, revealed by University of Minnesota ...
Dec 19, 2016
Insurance expansion under the ACA provides patients with greater hospital choice
During the first year of Medicaid expansion under the Affordable Care Act (ACA), researchers have seen a meaningful shift in the location and type of emergency department services used by patients. These changes suggest that ...
Dec 19, 2016
FDA clears ovarian cancer drug for hard-to-treat disease
U.S. health officials have approved a new option for some women battling ovarian cancer: a drug that targets a genetic mutation seen in a subset of hard-to-treat tumors.
Dec 19, 2016